Advertisement

Surveillance in Oral Cancer

  • Vijay PillaiEmail author
  • M. Abraham Kuriakose
Chapter

Abstract

Oral cancer management involves a multidisciplinary approach with integration of surgical, radiation and medical oncology modalities. In addition, it also needs inputs from the rehabilitative team encompassing speech and swallow, dental, nutrition, psychosocial counselling, behavioural modification and substance abuse. Treatment-related complications and issues manifest across all the disciplines involved in the cancer treatment. Hence, the importance of surveillance arises in patients treated for oral cancer.

References

  1. 1.
    Survival, epidemiology and end results program website. http://seer.cancer.gov/faststats/selections.php?#Output.
  2. 2.
    Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist. 2010;15(9):994–1001.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Fuller CD, Wang SJ, Thomas Jr CR, et al. Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973–1988. Cancer. 2007;109(7):1331–43.CrossRefPubMedGoogle Scholar
  4. 4.
    van der Schroeff MP, van de Schans SA, Piccirillo JF, et al. Conditional relative survival in head and neck squamous cell carcinoma: permanent excess mortality risk for long term survivors. Head Neck. 2010;32(12):1613–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Panwar A, Cheung VWF, Lydiatt WM. Supportive care and survivorship strategies in management of squamous cell carcinoma of the head and neck. Hematol Oncol Clin N Am. 2015;29:1159–68.CrossRefGoogle Scholar
  6. 6.
    Salz T, Oeffinger KC, Mc Cabe MS, et al. Survivorship care plans in research and practice. CA Cancer J Clin. 2012;62(2):101–17.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    National Research Council. Cancer patient to cancer survivor: lost in transition. Washington, DC: The National Academies Press; 2005.Google Scholar
  8. 8.
    Stricker CT, Jacobs LA, Risendal B, et al. Survivorship care planning after the Institute of Medicine recommendations: how are we faring? J Cancer Surviv. 2011;5(4):358–70.CrossRefPubMedGoogle Scholar
  9. 9.
    Institute of Medicine. Clinical practice guidelines we can trust. Washington, DC: The National Academies Press; 2011.Google Scholar
  10. 10.
    National Comprehensive Cancer Network clinical practice guidelines in oncology survivorship. http://www.nccn.org/professionals/physician_gls/pdf/survivorship.pdf.
  11. 11.
    Practice guidelines: ASCO institute for quality. http://www.instituteforquality.org/practice-guidelines.
  12. 12.
    Gregoire V, Lefebvre JL, Licitra L, et al. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v184–6.CrossRefPubMedGoogle Scholar
  13. 13.
    D’cruz A, Lin T, Anand AK, et al. Consensus recommendations for management of head and neck cancer in Asian countries: a review of international guidelines. Oral Oncol. 2013;49:872–7.CrossRefPubMedGoogle Scholar
  14. 14.
    National Comprehensive Cancer Network clinical practice guidelines in oncology-head and neck cancer. http://www.nccn.org/professionals/physician-gls/pdf/head-and-neck.pdf. Accessed Sept 2016.
  15. 15.
    Ritoe SC, Krabbe PF, Kaanders JH, et al. Value of routine follow-up for patients cured of laryngeal carcinoma. Cancer. 2004;101:1382–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Schwartz DL, Barker Jr J, Chansky K, et al. Post radiotherapy surveillance practice for head and neck squamous cell carcinoma- too much for too little? Head Neck. 2003;25:990–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Francis DO, Yueh B, Weymuller EA, et al. Impact of surveillance on survival after laryngeal cancer in the medicare population. Laryngoscope. 2009;119:2337–44.CrossRefPubMedGoogle Scholar
  18. 18.
    Roman BR, Patel SG, Wang M, et al. Guideline familiarity predicts variation in self reported use of routine surveillance PET/CT by physicians who treat head and neck cancer. J Natl Compr Cancer Netw. 2015;13:69–72.CrossRefGoogle Scholar
  19. 19.
    Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–65.CrossRefPubMedGoogle Scholar
  20. 20.
    Roman BR, Goldenberg D, Givi B, Education Committee of American Head and Neck Society (AHNS). AHNS series- do you know your guidelines? Guideline recommended follow-up and surveillance of head and neck cancer survivors. Head Neck. 2016;38:168–74.CrossRefPubMedGoogle Scholar
  21. 21.
    Kim JW, Roh JL, Kim JS, et al. (18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma. Br J Cancer. 2013;109:2973–9.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Pasha MA, Marcus C, Fakhry C, et al. FDG PET/CT for managing and assessing outcomes of squamous cell cancer of the oral cavity. AJR Am J Roentgenol. 2015;205:W150–61.CrossRefPubMedGoogle Scholar
  23. 23.
    Kosmider S, Field K, Jefford M, et al. Surveillance following treatment for colorectal cancer in Australia. Has best practice been adopted by medical oncologists? Intern Med J. 2008;38:415–21.CrossRefPubMedGoogle Scholar
  24. 24.
    Dinan MA, Curtis LH, Hammill BG, et al. Changes in the use and costs of diagnostic imaging among medicare beneficiaries with cancer, 1999–2006. JAMA. 2010;303:1625–31.CrossRefPubMedGoogle Scholar
  25. 25.
    Thompson CA, Charlson ME, Schenkein E, et al. Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors. Ann Oncol. 2010;21:2262–6.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Huang B, Law MW, Khong PL. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology. 2009;251:166–74.CrossRefPubMedGoogle Scholar
  27. 27.
    Slalom RG, Hornbook MC, Fishman PA, et al. Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer. 2012;118:5644–51.CrossRefGoogle Scholar
  28. 28.
    Morris LG, Sikora AG, Hayes RB, et al. Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Cancer Causes Control. 2011;22:671–9.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Atienza JA, Dasanu CA. Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature. Curr Med Res Opin. 2012;28:1899–909.CrossRefPubMedGoogle Scholar
  30. 30.
    Maxi SS, Pinheiro LC, Patil SM, et al. Causes of death in long-term survivors of head and neck cancer. Cancer. 2014;120:1507–13.CrossRefGoogle Scholar
  31. 31.
    Jayaprakash V, Cheng C, Reid M, et al. Previous head and neck cancers portend poor prognoses in lung cancer patients. Ann Thorac Surg. 2011;92:1056–60. discussion 1060–1051CrossRefPubMedGoogle Scholar
  32. 32.
    National Lung Screening Trial Research Team, Church TR, Black WC, et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med. 2013;368:1980–91.CrossRefGoogle Scholar
  33. 33.
    Wood D, et al. NCCN Clinical Practice Guidelines in Oncology for Lung Cancer Screening. V.1.2016. National Comprehensive Cancer Network, Inc; 2015. All rights reserved. Available at NCCN.org. Accessed 6 Sept 2016.Google Scholar
  34. 34.
    Wender R, Fontham ET, Barrera Jr E, et al. American Cancer Society Lung Cancer screening guidelines. CA Cancer J Clin. 2013;63:107–17.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Nayan S, Gupta MK, Strychowsky JE, et al. Smoking cessation interventions and cessation rates in the oncology population: an updated systematic review and met analysis. Otolaryngol Head Neck Surg. 2013;149:200–11.CrossRefPubMedGoogle Scholar
  36. 36.
    Cohen EEW, LaMonte SJ, Erb NL, et al. American Cancer Society head and neck cancer survivorship care guideline. CA Cancer J Clin. 2016;66:203–39.CrossRefPubMedGoogle Scholar
  37. 37.
    Rajaraman P, Anderson BO, Basu P, et al. Recommendations for screening and early detection of common cancers in India. Lancet Oncol. 2015;16:352–61.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Mazumdar-Shaw Cancer Center, Narayana Health CityBangaloreIndia
  2. 2.Department of Head and Neck Plastic and Reconstructive SurgeryRoswell Park Cancer InstituteBuffaloUSA

Personalised recommendations